Skip to main content
EM

EverBridge Medical

Bridgetech develops medical technology solutions for managing and treating prevalent chronic diseases. Their platform aims to improve patient outcomes and healthcare delivery for conditions affecting large populations.

Founded 20218100+ followers
Updated 15 months ago

Funding

$137.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

CB
Funding rounds are not available yet.

Founders

Product

Problem

Managing and treating chronic diseases often requires a diverse range of medical technologies and solutions across different clinical areas. Healthcare providers and patients may face challenges in accessing comprehensive and integrated solutions for specific disease management needs.

Solution

Bridgetech (瑞桥鼎科) is a medical technology company focused on building a global platform for prevalent chronic diseases, offering a range of solutions for disease management and treatment. The company develops and provides medical devices and integrated solutions across multiple therapeutic areas, including peripheral vasculature, neuroscience, and tumor management. Bridgetech leverages its research and development capabilities and technology platforms to create value and commercialize its products, aiming to provide innovative, high-quality, and affordable healthcare technologies to patients worldwide.

Target Audience

Bridgetech's primary customers include healthcare providers, hospitals, and medical professionals involved in the diagnosis, treatment, and management of chronic diseases, as well as patients seeking advanced medical technology solutions.

Features

  • Offers a range of products for peripheral vascular interventions, including balloon catheters, guidewires, and accessories.
  • Provides solutions for neurovascular interventions, including embolization coils, catheters, and guidewires for treating ischemic and hemorrhagic stroke.
  • Develops integrated solutions for tumor diagnosis and treatment, covering screening, diagnosis, therapy, and rehabilitation.
  • Employs six core technology platforms, including multi-adaptive balloons, full-function catheters, cross-scenario stents, bio-interface coatings, high-performance guidewires, and intelligent powered equipment.
  • Utilizes an EBS (Excellent Business System) for lean value management to drive commercialization and value creation.
This profile is AI-generated and may contain inaccuracies.